ArticleAssay and drug development technologies2017

When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.

Jill M Pulley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.